Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #36303190 -6034-11f1-a4ae-b1e009c35ae0

Itron Inc. (NASDAQ:ITRI) is one of the 10 technology stocks offering more than 50% upside.
On May 26, Itron Inc. (NASDAQ:ITRI) announced the expansion of its strategic collaboration with Hunter Water. The purpose of this partnership is to help accelerate the utility’s digital water transformation through its formalized Digital Metering Pilot Program. It uses advanced data tracking to reduce non-revenue water loss and radically improve water network management.
Copyright: kosmos111 / 123RF Stock Photo
At the same time, the program makes it possible for consumer-side consumption transparency to boost long-term conservation initiatives. Itron Intelis wSource NB-IoT ultrasonic water meters are specifically integrated as part of the utility’s deployment of a diversified ****** et mix as a core operational phase. Additionally, these deployed devices will be managed through Temetra, Itron’s cloud-based, multi-vendor, multi-commodity meter data management solution, which is already in use by the utility.
Apart from these recent developments, ****** yst ratings also indicate promising prospects for the stock. Back on April 29, Roth Capital ****** yst Chip Moore updated his view of Itron Inc. (NASDAQ:ITRI) after the company reported its first quarter earnings and shared a lower second quarter forecast relative to market consensus. Moore maintained his Buy rating on the shares. He decreased the firm’s price target from $150 to $136, which still results in an upside potential of almost 65%.

Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #36303190 -6034-11f1-a4ae-b1e009c35ae0

The Detroit Lions have added another receiver to their offseason roster.
On Wednesday, the team announced that it has signed wide receiver Kyre Duplessis, adding another young playmaker to compete for a spot during training camp.
The move comes shortly after the Lions learned that rookie fifth-round pick Kendrick Law will miss the 2026 season after suffering a torn ACL.
Duplessis enters the NFL after a productive career with the Delaware Blue Hens.
During the 2025 season, the 5-foot-11, 190-pound receiver hauled in 60 receptions for 824 yards and five touchdowns while averaging 13.7 yards per catch.

Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #36303190 -6034-11f1-a4ae-b1e009c35ae0

Having come on strong in this year’s French Open, Diana Shnaider’s explosive left-handed forehand and double-handed backhand aren’t her only signatures.

The Russian-born player, who is recognizable for her colorful headscarves, is squaring off against Maja Chwalińska of Poland Thursday. Shnaider opted for a repeat look, wearing the same orange headscarf and black Yonex tennis dress that she wore Wednesday to defeat the WTA’s top-ranked Aryna Sabalenka. As for her French Open strategy, Shnaider told reporters earlier this week that she was “trying to go match by match.”

The Yonex-sponsored athlete was unmissable in an orange ribbed headscarf that accented the orange and turquoise trim on her black tennis dress with a leathery-looking pleated skirt. It also coordinates with the red clay courts at Roland-Garros.

Born in Zhigulevsk, Russia, Shnaider started playing tennis at the age of 4 and was training under coach Samvel Minasyan in Moscow by the age of 8. After a stint at North Carolina State University in 2022, she competed in her first Grand Slam tournament the following year at the Australian Open. Repped by Topnotch Management, the former Adidas-sponsored athlete has an endorsement deal with the sports media content company First & Red. Her career earnings to date are $5.17 million including $952,112 in prize earnings. This year women’s single winner at the French Open will take home 2,800,000 euros, or $3.25 million.

Her signature headscarf was something that she started wearing years ago to shield the sun. Shnaider’s parents were concerned that the fair-haired daughter would get sunburned on the courts, but caps and visors reportedly obstructed her view. So Shnaider opted for a headscarf that they bought in a supermarket. By 2023, Shnaider was outsourcing the design of her favorite accessory, by buying the material for a seamstress to design. However, for Wednesday’s upset victory, she appeared to wear a ribbed one with the Yonex logo on it. A Yonex representative deferred an interview request to Topnotch Management, which did not respond to requests for comment.
The American men’s singles player Frances Tiafoe copied the look last year by sporting a blue headscarf with white polka dots at last year’s Cincinnati Open. He gave her credit for the choice via Instagram inspiration on Instagram with “New look?? Appreciate u _di_shnaider_ .”
More from WWD
Battle of the Brands: How Nike, Adidas and More Will Duke It Out Across World Cup Product, Marketing and Activations
Brands and Labels Celebrating the 2026 FIFA World Cup: Puma, Kith, Adidas and More

Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #36303190 -6034-11f1-a4ae-b1e009c35ae0

Cincinnati Bengals tight end Erick All Jr. aims to put his injuries behind him after missing 43 games dating back to his final season with the Michigan Wolverines in 2022 and his lone season with the Iowa Hawkeyes in 2023. He missed 11 games in 2022 with a significant back injury that required surgery. All then missed seven games in 2023 due to a torn right ACL. He tore the same ACL in his rookie season, missing eight games and the entire 2025 campaign.
All has since fully recovered and has been a full participant in voluntary organized team activities. He will compete for a roster spot, and if he can pick where he left off in both the blocking and receiving departments, he could earn a place on the 53-man roster.
During Tuesday’s press conference, Erick All Jr. was asked about his health after recently recovering from a pair of ACL injuries, as reported by Billy Riccette of Bengals Wire. He said he feels much better than when he first arrived in Cincinnati in 2024 and is now completely healthy. All also emphasized his physicality, saying he “is in heaven” when coaches have him hit.
“I love to hit. If they have me hit, I’m in heaven,” All said, via Riccette.
“If I’m being quite honest, I feel a lot better than I did when I first got here. Like, a lot better. Completely healthy, 2024 season to now, I feel like a completely different person.

Baseball is the Spitaleri family business and, right now, business is booming.
Led senior Sean Spitaleri, Glen Rock is back in the North 1, Group 2 sectional final June 5, taking on Ramsey. Spitaleri is a pitcher/first baseman with a 9-1 record on the hill, a team-high 15 doubles and 28 RBIs. He's the North Jersey Male Athlete of the Week, presented by HSS.
Spitaleri couldn’t escape baseball even if he wanted to – news flash, he doesn’t – his father, Steve, is the Panther's head coach and his brother Jack is a starting outfielder.
“I am not here without my teammates or my coaches,” Spitaleri said after getting home from the Panthers sectional semifinal win in Vernon on June 3. “My whole team deserves a lot of recognition. I’m super lucky to be surrounded by a bunch of great guys, our bench guys bring energy and effort and that fires me up to give 110 percent.”
Sean has heard the question his entire high school career: What’s it like to have your dad as a coach? The answer is he loves it. Steve was a standout at Dominican University and runs a private baseball academy. Sean remembers being exposed to baseball growing up but not overly pushed in that direction.

The New England Patriots have made a change to their offseason program schedule.
According to ESPN’s Mike Reiss, the Patriots moved their mandatory minicamp from June 15-17 to June 9-11, as head coach Mike Vrabel confirmed to media members on Tuesday.
The Patriots will hold their mandatory minicamp for veteran players, as stipulated in the NFL’s collective bargaining agreement. Physicals will be administered on June 8, before the team goes through on-field activities.
New England’s second practice of the minicamp will entail walkthroughs only. No live contact will be permitted throughout the three days of the mandatory camp.
The Patriots acquired superstar wide receiver A.J. Brown in a trade with the Philadelphia Eagles on June 1, changing the complexion of their roster even further this spring. They will continue to get Brown and the team into shape once the mandatory minicamp takes place next week.

GREEN BAY – Less than a year ago, while still rehabbing from his torn ACL late in the 2024 season, Christian Watson got a little patience from the Green Bay Packers with a one-year extension.
It provided a runway for Watson to return without the pressure of a contract expiration hanging over him. More time to prove he was back to full speed.
Turns out, he didn’t need it.
Watson reached an agreement on a second extension June 4, a four-year, $110.5 million deal that will retain the Packers’ top receiver long term, according to ESPN’s Adam Schefter. The deal includes a $31 million signing bonus and dwarfs the one-year extension worth up to $13.25 million he signed last September.
The new extension makes Watson the NFL’s 15th-highest-paid receiver at $27.625 million annually. Watson might have scaled higher on the market with a healthy season this fall, but much like Jayden Reed did earlier this offseason, opted for more security up front.

What Christian Watson’s extension really says about Jordan Love and the Packers originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
The Green Bay Packers are locking up wide receiver Christian Watson for the long haul on a mega multi-year extension.
According to ESPN's Adam Schefter, Watson is signing a four-year deal worth $110.5 million to remain in Green Bay. The contract also includes a $31 million signing bonus.
Watson was set to hit free agency next offseason, and though the young receiver has shown promise through four seasons, he has been unable to stay healthy and post consistent production when on the field.
2026 has been considered a make-or-break year for Watson, but the Packers have decided to sign him to a long-term extension before training camp kicks off, which tells us a lot about quarterback Jordan Love and Green Bay's offense.

Russell Wilson’s retirement marks the end of one of the most accomplished quarterback careers of the modern NFL era. After 14 seasons, a Super Bowl championship, ten Pro Bowl selections, and nearly 47,000 passing yards, Wilson announced Wednesday that he is stepping away from football. The longtime Seattle Seahawks star leaves the game as one of the most productive dual-threat quarterbacks in league history, finishing his career with 353 touchdown passes and more than 5,500 rushing yards.
In an announcement on Twitter/X, Wilson announced his retirement and addressed many different people along the way, including former Seattle Seahawks head coach Pete Carroll.
“To coach Carroll, thanks for taking a chance on a young, 5-11 Black kid from Richmond, Virginia, that was told he was too small to ever make it ⁠in the NFL,” Wilson said. “We knew what winning was like. And to every teammate I’ve had the privilege of sharing the ⁠locker room with, thank you for the sacrifices, the brotherhood, the memories. None of this is possible without you.”
Wilson’s retirement may be fresh, but that is not stopping him from continuing to work in the field that he loves. He has accepted a position with CBS Sports as an ******* yst for the upcoming 2026 football season.
“As I enter this next chapter with CBS Sports and The NFL Today, I’m so blessed to continue doing what I love most, being around the greatest game in the world,” Wilson said.

This future Army athlete has plenty of motivation to serve his country and compete for the Black Knights.
Adis Hamidovic, a senior at Bloomington North High School in Indiana, has committed to throw for the Army track and field team. He's determined to follow in the footsteps of his mom, Sara, who played multiple sports for Army in the early 2000s. He'll join a Army track program led by coach Mike Smith, who has been named Patriot League Men's Coach of the Year five times since coming to West Point in 2014.
Hamidovic is one of the best throwers in Indiana and could be set up for a big performance this weekend at the IHSAA track and field finals. He took first in the discus (185 feet, one inch) and third in the shot put (56 feet, 7.5 inches) at last week's regional meet. He enters Friday's finals ranked third in the discus and 11th in the shot put.
Sara is bursting with pride over the choice her son has made about his future.
At the same time, it's hard to keep from crying when she talks about exactly where his decision could lead him. She knows firsthand — and it scares the ***** out of her.

The New York Islanders may lose their captain to free agency, and the New Jersey Devils play a major role in the situation.
Anders Lee’s seven year contract is up on July 1st and he’s set to become an unrestricted free agent.
The Islanders and Lee have been here before. However, at the 11th hour back in 2019, Lee and the Islanders agreed to terms on an extension to keep the captain on Long Island.
Yet, this isn’t Lou Lamoriello’s Islanders anymore. It’s Mathieu Darche in the GM chair these days. And now Lee and the Islanders are back at it in this game of chicken.
According to NHL insider Pierre LeBrun, Lee and his agent are preparing to hit free agency on July 1st.

This story initially appeared on PittsburghBaseballNow.com.
The Pittsburgh Pirates looked poised to cruise to their fifth straight win, but the bullpen collapsed in grand fashion in the eighth inning, resulting in an unimaginable 11-9 loss to the Houston Astros at Daikin Park on Wednesday night.
Bottom 3rd, 2-0 HOU: With two on and one out, Yordan Alvarez ripped a base hit to right field to give the Astros (28-35) the lead against Paul Skenes. Later in the inning, Houston had runners on the corners with two outs, and third baseman Nick Gonzales couldn’t make a play on a hard grounder. It was scored an RBI single for Isaac Paredes.
Top 4th, 4-2 PIT: With the bases loaded and two outs, Henry Davis launched a grand slam to left field off Astros starter Spencer Arrighetti to give the Pirates (33-29) the lead. The blast hit the train tracks above the left field stands traveled 396 feet.
Bottom 5th, 4-3 PIT: Skenes labored threw the fifth inning and Cam Smith delivered a two-out RBI single on the right-hander’s 3-2 pitch, his career-high 109th offering of the game.

If you buy something through a link in this article, we may earn commission.
In the weeks leading up to the 2026 World Cup, many of the participating teams have been keeping in shape by competing in pre-tournament matches against other national teams, and tonight, Mexico will face off against Serbia in a friendly match at Estadio Nemesio Diez in Toluca, Mexico. This will be the last friendly for both teams before the tournament begins on June 11.
Coverage of tonight’s Mexico vs. Serbia match will begin at 9 p.m. ET and kickoff is scheduled for 10 p.m. ET on TUDN and Univision, which are available on streaming services like DirecTV and YouTube TV. Here’s everything you need to know about how to watch Mexico vs. Serbia.
Date: Thursday, June 4
Time: 10 p.m. ET

There's been a significant amount of interest in tracking New York Jets rookie quarterback Cade Klubnik at OTAs.
Understandably so. The fanbase is looking for a young quarterback to attach hope to. Klubnik had impressed in early sessions, but Tuesday's was of the rougher variety.
Klubnik went 2-of-5 during 11-on-11 team drills, according to ESPN. The former Clemson standout overthrew his target on one incompletion and there was an errant throw on another dropback. It's worth noting one of Klubnik's three incompletions was a dropped pass.
Offensive coordinator Frank Reich's 7-on-7 drills reportedly weren't any kinder to Klubik.
The fourth-round quarterback finished 3-of-9. He threw an interception down the sideline to cornerback Tre Brown. The turnover appeared to have rattled Klubnik, who followed his interception with a few more misfires. The Jets' offense reportedly worked on a lot of third-and-long, placing the rookie quarterback at a disadvantage.

The Oklahoma Sooners have built quite the 2027 recruiting class over the last few months, and it continues to grow even stronger. OU currently has 23 commitments for this cycle, with 12 coming on the offensive side of the ball, and 11 coming on the defensive side of the ball.
Furthermore, those that follow high school football recruiting closely were excited about the state of Oklahoma's crop of high school players in the 2027 class. Many have called it a historically good cycle for the state, perhaps even the best ever. Both Rivals and 247Sports back those claims up. Both sites have three players from the state in the top 50 of their national player rankings, something that has never happened before for the state of Oklahoma.
Each of those three players, Fort Gibson's Cooper Hackett, Bixby's Kaeden Penny, and Mustang's Gabriel Osborne Jr., are committed to the Sooners, meaning that OU head coach Brent Venables and general manager Jim Nagy not only swept the consensus top three players in the state, they swept the consensus top three players in the state in possibly the state's best class ever.
Hackett stands at 6-foot-7, and weighs 260 pounds. He is ranked as the nation's No. 17 player by Rivals and the No. 14 player nationally by 247Sports Composite. The offensive lineman has an extremely high athletic ceiling and he moves well for his size. He is a player that the Sooners are pinning their future hopes at offensive tackle on.
Penny checks in at 6-foot-4 and weighs 265 pounds. Rivals ranks him as No. 32 player in the country, with 247Sports Composite ranking him at No. 37. The offensive lineman displays strong footwork and body control, especially when it comes to pass protection. He's capable of playing both offensive tackle or lining up in the interior of the offensive line.

EXCLUSIVE: Comedian and actor Adam Buxton will attempt to combat his mid-life crisis and existential anxiety in an Audible podcast series.
Successpod will see the Hot Fuzz actor, who forms one half a comedy duo with director Joe Cornish, exploring what it takes to be a 'success' in the modern world. Mindhouse Studios, the podcast arm of Louis Theroux's Mindhouse, is producing, and the show launches on June 11.
More from Deadline
Louis Theroux's Mindhouse & Soho Studios Land First U.S. Cable Show With A+E's 'Predator Hunters'
Louis Theroux Confirms Netflix Manosphere Documentary & Opens Mindhouse Podcast Division, As He Addresses Bob Vylan Pod Criticism: "I'm Willing To Have Difficult Conversations & Long May It Continue"

The World Health Organization has said efforts to contain the Ebola epidemic are “catching up”, despite the virus having had a “big head start.”
This week, WHO reported a major drop in the number of suspected Ebola cases in the Democratic Republic of Congo (DRC) outbreak, after testing ruled out many of them.
WHO Director-General Tedros Adhanom Ghebreyesus said on Wednesday there were now 344 confirmed cases of Ebola in the DRC outbreak and 116 suspected cases — a significant drop from the 1,000-plus suspected cases.

HOUSTON (AP) — Cam Smith hit a tiebreaking two-run triple to cap Houston’s six-run eighth inning, Isaac Paredes homered and the Astros overcame a five-run deficit to beat the Pittsburgh Pirates 11-9 on Wednesday night.
Yordan Alvarez had four hits and two RBIs for the Astros. Smith and Paredes had two hits and three RBIs apiece, and Jeremy Peña went 2 for 3 with a double.
AJ Blubaugh (3-2) pitched the eighth inning to get the victory. Josh Hader made his season debut and worked a scoreless ninth for the save, ending the Pirates' winning streak at four.
Houston starter Spencer Arrighetti, who went 4-1 in five starts with a 0.93 ERA in May, allowed four runs in four innings.
Henry Davis hit his first career grand slam in the fourth inning for Pittsburgh. Nick Gonzalez had a homer, double and three RBIs.

It's not the first time Connor Basye has answered the call.
Back in 2015, after his senior season with the Bloomington North basketball team was done, former Cougar head coach Andy Hodson called Basye at 11:30 the night before the Hoosier Basketball Coaches ****** ociation All-Star game was to be held at the Cougar Den. Hodson wondered if he'd like to fill a spot on a roster after another player couldn't make it.
"It was awesome," Basye said at the time. "Even better since we got the win."
More: Bloomington area athletes to watch at IHSAA boys state track meet
Several days ago, Edgewood athletic director Jerry Bland called him up, only this time, the question was whether Basye would like to be the new head boys basketball coach for the Mustangs. Like before, his answer was yes. And yes, he expects to win this time as well.

The Toronto-Dominion Bank (NYSE:TD) is one of the best inexpensive stocks to invest in right now. On May 29, CIBC lifted the price target on The Toronto-Dominion Bank (NYSE:TD) to C$164 from C$151 while maintaining a Neutral rating on the shares. The company also received a rating update from Barclays the same day, with the firm raising the price target on the stock to C$140 from C$135 and reiterating an Underweight rating on the shares.
The rating updates came after the bank reported financial results for fiscal Q2 2026, which ended April 30, 2026, in which it announced that reported diluted earnings per share were $2.43, compared with $6.27 in the prior year period, while adjusted diluted earnings per share were $2.38, compared to $1.97 in fiscal Q2 2025. Reported net income for the quarter was $4,251 million, compared with $11,129 million, with the adjusted net income reaching $4,168 million, compared with $3,626 million in the prior year period.
The Toronto-Dominion Bank (NYSE:TD) provides financial products and services. Its operations are divided into the following segments: Canadian Personal and Commercial Banking, U.S. Retail, Wealth Management and Insurance, Wholesale Banking, and Corporate segment.
While we acknowledge the potential of TD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Royal Bank of Canada (NYSE:RY) is one of the best inexpensive stocks to invest in right now. TD Securities lifted the price target on Royal Bank of Canada (NYSE:RY) to C$272 from C$267 on May 29 and maintained a Buy rating on the shares. Royal Bank of Canada (NYSE:RY) also received a rating update from Barclays the same day, with the firm raising the price target on the stock to C$260 from C$245 and maintaining an Overweight rating on the shares.
For reference, in its financial results for the quarter ended April 30, 2026, the company reported net income of $5.5 billion, up $1,119 million or 25% from the previous year. Diluted EPS rose 27% over the same period to $3.85, highlighting growth across each of Royal Bank of Canada’s (NYSE:RY) business segments. Adjusted net income and adjusted diluted EPS for the quarter were $5.6 billion and $3.90, up 23% and 25%, respectively, from the prior year.
Royal Bank of Canada (NYSE:RY) provides banking and financial services. The company’s operations are divided into the following segments: Personal and Commercial Banking, Wealth Management, Insurance, Capital Markets, and Corporate Support.
While we acknowledge the potential of RY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Zoetis Inc. (NYSE:ZTS) is among the most undervalued stocks to invest in.
TheFly reported on May 27 that Argus downgraded ZTS from Buy to Hold following a sharp decline in the company’s share price, including a steep one-day drop of about 22% and continued subsequent weakness. The move reflects growing investor concern over the company’s near-term growth outlook and reduced confidence in its performance trajectory. The ****** yst noted that recent price action signals a shift in market sentiment, with pressure on the stock driven by deteriorating expectations rather than a single operational event.
In addition to that, earlier on May 7, Zoetis Inc. (NYSE:ZTS) released its financial results for the first quarter of 2026, reporting revenue of $2.3 billion, which reflected a 3% increase compared with the same period in 2025 and was flat on an organic operational basis. Net income totaled $601 million, or $1.42 per diluted share, showing stable performance on a reported basis with 6% per-share growth. Adjusted net income reached $646 million, or $1.53 per diluted share, representing 2% and 9% increases on a reported basis and 1% and 7% growth on an organic operational basis.
Goodluz/Shutterstock.com
The company noted a more challenging operating environment, including weaker veterinary visits and softer demand in companion animal products, alongside intensified competition. However, livestock and international segments delivered growth across cattle, poultry, swine, diagnostics, and parasiticides, partially offsetting U.S. declines and supporting overall portfolio resilience.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Prestige Consumer Healthcare Inc. (NYSE:PBH) is among the most undervalued stocks to invest in.
TheFly reported on May 15 that Canaccord Genuity cut its price target on PBH from $86 down to $72 while keeping a Buy rating in place. The adjustment came after a weaker Q4 result, driven largely by softness in the eye care segment along with additional pressure linked to the Iran conflict, prompting the firm to revise its model.
Separately, on May 13, Prestige Consumer Healthcare Inc. (NYSE:PBH) disclosed a definitive agreement to acquire LaCorium Health in an all-cash deal valued at about $150 million. The transaction is still subject to standard closing conditions and is expected to be completed during the second quarter of fiscal 2027. Based on financial data provided, LaCorium recorded roughly $40 million in revenue over the trailing twelve months ending February 28.
The business is projected to contribute around $12 million in EBITDA after the anticipated benefits from integration synergies are realized. In addition, LaCorium is expected to deliver double-digit net sales growth during calendar year 2026, indicating continued expansion before full integration. The acquisition is positioned as a strategic addition that will be incorporated into Prestige’s broader operations once finalized, strengthening its portfolio and supporting longer-term growth and profitability objectives within its consumer healthcare segment.
Prestige Consumer Healthcare Inc. (NYSE:PBH) is a leading provider of over-the-counter health, wellness, and personal care products. Headquartered in Tarrytown, New York, it manages a portfolio of well-known consumer health brands.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is one of the most undervalued pharma stocks.
TheFly reported on May 11 that Piper Sandler reduced its price target on AMPH from $25 to $21 while maintaining a Neutral stance on the stock following the company’s quarterly results. The firm noted that AMPH has several complex generic products and branded opportunities in its pipeline, but there is limited clarity on when these programs will begin to generate meaningful results. This lack of visibility into the timing of potential pipeline catalysts contributed to the revised outlook.
Earlier on May 7, Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) released its financial results for the first quarter ended March 31, 2026. The company posted net revenues of $171.2 million for the period. Reported GAAP net income came in at $6.4 million, translating to earnings of $0.14 per share. On an adjusted non-GAAP basis, net income was $19.5 million, or $0.42 per share.
The results reflect performance across its portfolio of technically complex generic and proprietary injectable, inhalation, and intranasal products. The figures provide a snapshot of profitability under both standard accounting measures and adjusted metrics that exclude certain items. These quarterly outcomes highlight the company’s financial position and operational results for the period, offering investors a view of revenue generation and earnings performance during the first quarter of fiscal 2026.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a biopharmaceutical company that develops and markets generic and proprietary injectable, inhalation, and intranasal products. It focuses on complex, hard-to-make medications used in hospitals and clinical settings.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. GSK plc (NYSE:GSK) is one of the most undervalued stocks in the pharma sector.
TheFly reported on May 7 that GSK launched a public health awareness initiative under its Ask2BSure campaign, introducing Julie Bowen and Ty Burrell as campaign advocates to promote education around meningococcal disease, also known as meningitis. The effort encourages parents to better understand infection risks and discuss vaccination with healthcare providers.
The campaign includes an educational video ****** led The Mening-Itinerary, which illustrates everyday teen environments such as dorms, gyms, and social gatherings where bacterial transmission may occur. The content also highlights survivor experiences and aims to address gaps in parental awareness about disease risk and prevention. The initiative is designed to strengthen public understanding of meningitis and support informed vaccination decisions through storytelling and outreach.
Expanding its global commercial footprint, on May 11, GSK plc (NYSE:GSK) entered into an exclusive strategic collaboration with Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and commercialization of bepirovirsen in mainland China. Bepirovirsen is an investigational first-in-class therapy for chronic hepatitis B and is currently under priority regulatory review in China. The partnership combines GSK’s research and development capabilities with CTTQ’s established liver disease franchise and extensive hospital access network across thousands of medical centers.
Under the agreement, CTTQ will manage importation, distribution, and promotional activities in China, while GSK retains global regulatory, safety, and medical oversight responsibilities. The collaboration also includes potential evaluation of select early-stage ****** ets for future partnership opportunities beyond China.

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most undervalued stocks to invest in.
TheFly reported on May 27 that GILD presented long-term interim findings from the ongoing Phase 3 ***** URE study of Livdelzi at the 2026 European ***** ociation for the Study of the Liver Congress in Barcelona. A post hoc ***** ysis showed sustained improvement in liver function markers among patients with primary biliary cholangitis who had persistently elevated alkaline phosphatase despite prior first-line therapy.
Across treated participants, ALP levels declined, and a high proportion achieved biochemical normalization over extended follow-up, with durable responses observed up to two years. Additional ***** yses indicated stability in other indicators of cholestasis and liver stiffness over time. The safety profile remained consistent with earlier findings, with no treatment discontinuations due to adverse events and no new safety concerns identified.
In an interconnected pipeline development, Gilead Sciences, Inc. (NASDAQ:GILD) announced on May 22 that the European Medicines Agency’s CHMP issued a positive opinion recommending marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as a first-line monotherapy option for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer who are not eligible for PD-1 or PD-L1 inhibitor therapy.
The decision is based on Phase 3 ASCENT-03 results demonstrating statistically significant and clinically meaningful improvement in progression-free survival compared with standard chemotherapy, including a 38% reduction in the risk of disease progression or death. Metastatic TNBC remains a highly aggressive cancer with limited first-line options and poor outcomes. The recommendation now proceeds to the European Commission for final review, with a decision expected later in 2026.